Target intelligence / Profile preview

Influenza A virus hemagglutinin protein H3 (Hemagglutinin H3 of Influenza A virus) (HA (specifically H3 subtype))

Target
HA (specifically H3 subtype)
Molecular classification
Viral fusion protein, Viral attachment protein, Glycoprotein, Other (Class I fusion protein)
01

Overview

Hemagglutinin H3 is a **trimeric glycoprotein** found on the surface of the Influenza A virus, particularly the H3N2 subtype. It facilitates **viral entry into host cells** by binding to sialic acid–containing receptors on the cell surface and mediating the fusion of viral and host membranes after endocytosis. This dual function makes it essential for infectivity and pathogenicity. The HA protein is synthesized as a single precursor (HA0), which must be cleaved into HA1 and HA2 subunits for activation. HA is a major target of neutralizing antibodies, which block viral attachment and/or fusion. The H3 subtype is a major cause of **seasonal influenza** in humans and is associated with significant morbidity and mortality, especially among vulnerable populations. **Antigenic drift** in HA H3 enables the virus to evade preexisting immunity, necessitating frequent updates of influenza vaccines.

Other names
Hemagglutinin H3HA H3H3N2 hemagglutininInfluenza A HA H3Hemagglutinin (influenza)HA glycoprotein
02

Mechanism of action

Blocking viral attachment to host receptors (by antibodies); Inhibiting conformational changes required for membrane fusion (by antibodies)

03

Biological functions

Viral attachment to host cellsMediates virus–host membrane fusionMajor target of neutralizing antibodies
04

Disease associations

Infection (human influenza)Transmission/virulence factor for flu pandemics
05

Safety considerations

High antigenic drift leads to immune escape and requires frequent vaccine updatesPotential for zoonotic transmission and pandemic risk
06

Interacting drugs

None directly approved targeting the protein itself; however, monoclonal antibodies (investigational) and some broadly neutralizing antibodies target HA. Influenza vaccines elicit antibodies against HA, but these are not “drugs” per se
07

Biomarkers

Presence of H3 hemagglutinin gene or protein is a biomarker for Influenza A H3N2 infection/subtype in diagnostic assays

Beyond the preview

Go deeper on Influenza A virus hemagglutinin protein H3 (Hemagglutinin H3 of Influenza A virus) (HA (specifically H3 subtype)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin protein H3 (Hemagglutinin H3 of Influenza A virus) (HA (specifically H3 subtype)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call